135 related articles for article (PubMed ID: 27942171)
1. Development and validation of limited sampling strategy equation for mycophenolate mofetil in children with systemic lupus erythematosus.
Prabha R; Mathew BS; Jeyaseelan V; Kumar TS; Agarwal I; Fleming DH
Indian J Nephrol; 2016; 26(6):408-412. PubMed ID: 27942171
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic drug monitoring of mycophenolate mofetil and enteric-coated mycophenolate sodium in patients with systemic lupus erythematosus.
Djabarouti S; Duffau P; Lazaro E; Chapouly C; Greib C; Viallard JF; Pellegrin JL; Saux MC; Breilh D
Expert Opin Pharmacother; 2010 Apr; 11(5):689-99. PubMed ID: 20210680
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of mycophenolic acid and external evaluation of two limited sampling strategies of drug exposure in patients with juvenile systematic lupus erythematosus.
Beaulieu Q; Zhang D; Melki I; Baudouin V; Goldwirst L; Woillard JB; Jacqz-Aigrain E
Eur J Clin Pharmacol; 2022 Jun; 78(6):1003-1010. PubMed ID: 35294622
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of limited sampling strategies for the estimation of mycophenolic acid area under the curve in adult kidney and liver transplant recipients receiving concomitant enteric-coated mycophenolate sodium and tacrolimus.
Pawinski T; Luszczynska P; Durlik M; Majchrzak J; Baczkowska T; Chrzanowska M; Sobiak J; Glyda M; Kuriata-Kordek M; Kamińska D; Krajewska M; Klinger M
Ther Drug Monit; 2013 Dec; 35(6):760-9. PubMed ID: 24192641
[TBL] [Abstract][Full Text] [Related]
5. Limited sampling strategies drawn within 3 hours postdose poorly predict mycophenolic acid area-under-the-curve after enteric-coated mycophenolate sodium.
de Winter BC; van Gelder T; Mathot RA; Glander P; Tedesco-Silva H; Hilbrands L; Budde K; van Hest RM
Ther Drug Monit; 2009 Oct; 31(5):585-91. PubMed ID: 19704401
[TBL] [Abstract][Full Text] [Related]
6. Defining algorithms for efficient therapeutic drug monitoring of mycophenolate mofetil in heart transplant recipients.
Kaczmarek I; Bigdeli AK; Vogeser M; Mueller T; Beiras-Fernandez A; Kaczmarek P; Schmoeckel M; Meiser B; Reichart B; Ueberfuhr P
Ther Drug Monit; 2008 Aug; 30(4):419-27. PubMed ID: 18641552
[TBL] [Abstract][Full Text] [Related]
7. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil in patients with systemic lupus erythematosus: a prospective pharmacokinetic study.
Roland M; Barbet C; Paintaud G; Magdelaine-Beuzelin C; Diot E; Halimi JM; Lebranchu Y; Nivet H; Büchler M
Lupus; 2009 Apr; 18(5):441-7. PubMed ID: 19318398
[TBL] [Abstract][Full Text] [Related]
9. Limited sampling strategy and population pharmacokinetic model of mycophenolic acid in pediatric patients with systemic lupus erythematosus: application of a double gamma absorption model with SAEM algorithm.
Koloskoff K; Benito S; Chambon L; Dayan F; Marquet P; Jacqz-Aigrain E; Woillard JB
Eur J Clin Pharmacol; 2024 Jan; 80(1):83-92. PubMed ID: 37897528
[TBL] [Abstract][Full Text] [Related]
10. Generation and Validation of a Limited Sampling Strategy to Monitor Mycophenolic Acid Exposure in Children With Nephrotic Syndrome.
Benz MR; Ehren R; Kleinert D; Müller C; Gellermann J; Fehrenbach H; Schmidt H; Weber LT
Ther Drug Monit; 2019 Dec; 41(6):696-702. PubMed ID: 31425441
[TBL] [Abstract][Full Text] [Related]
11. How accurate and precise are limited sampling strategies in estimating exposure to mycophenolic acid in people with autoimmune disease?
Abd Rahman AN; Tett SE; Staatz CE
Clin Pharmacokinet; 2014 Mar; 53(3):227-245. PubMed ID: 24327238
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of limited sampling strategy for mycophenolic acid area under the curve considering postoperative days in living-donor renal transplant recipients with concomitant prolonged-release tacrolimus.
Enokiya T; Nishikawa K; Muraki Y; Iwamoto T; Kanda H; Sugimura Y; Okuda M
J Pharm Health Care Sci; 2017; 3():17. PubMed ID: 28652924
[TBL] [Abstract][Full Text] [Related]
13. Validation of limited sampling strategy for estimation of mycophenolic acid exposure during the first year after heart transplantation.
Baraldo M; Cojutti PG; Isola M; Feruglio MT; Tursi V; Livi U; Furlanut M
Transplant Proc; 2009 Dec; 41(10):4277-84. PubMed ID: 20005384
[TBL] [Abstract][Full Text] [Related]
14. The Evaluation of Multiple Linear Regression-Based Limited Sampling Strategies for Mycophenolic Acid in Children with Nephrotic Syndrome.
Sobiak J; Resztak M; Chrzanowska M; Zachwieja J; Ostalska-Nowicka D
Molecules; 2021 Jun; 26(12):. PubMed ID: 34207320
[TBL] [Abstract][Full Text] [Related]
15. Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure.
Tett SE; Saint-Marcoux F; Staatz CE; Brunet M; Vinks AA; Miura M; Marquet P; Kuypers DR; van Gelder T; Cattaneo D
Transplant Rev (Orlando); 2011 Apr; 25(2):47-57. PubMed ID: 21190834
[TBL] [Abstract][Full Text] [Related]
16. Limited sampling strategies for predicting area under the concentration-time curve of mycophenolic acid in islet transplant recipients.
Al-Khatib M; Shapiro RJ; Partovi N; Ting LS; Levine M; Ensom MH
Ann Pharmacother; 2010 Jan; 44(1):19-27. PubMed ID: 19996322
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolic acid area under the curve correlates with disease activity in lupus patients treated with mycophenolate mofetil.
Zahr N; Arnaud L; Marquet P; Haroche J; Costedoat-Chalumeau N; Hulot JS; Funck-Brentano C; Piette JC; Amoura Z
Arthritis Rheum; 2010 Jul; 62(7):2047-54. PubMed ID: 20506558
[TBL] [Abstract][Full Text] [Related]
18. Limited sampling strategy to predict mycophenolic acid area under the curve in pediatric patients with nephrotic syndrome: a retrospective cohort study.
Sobiak J; Resztak M; Pawiński T; Żero P; Ostalska-Nowicka D; Zachwieja J; Chrzanowska M
Eur J Clin Pharmacol; 2019 Sep; 75(9):1249-1259. PubMed ID: 31172249
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of limited sampling strategies for tacrolimus and mycophenolate in steroid-free renal transplant regimens.
Poulin E; Greanya ED; Partovi N; Shapiro RJ; Al-Khatib M; Ensom MH
Ther Drug Monit; 2011 Feb; 33(1):50-5. PubMed ID: 21157401
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of Mycophenolate Mofetil and Development of Limited Sampling Strategy in Early Kidney Transplant Recipients.
Zhang J; Sun Z; Zhu Z; Yang J; Kang J; Feng G; Zhou L; Zuo L; Luo Y; Zhang X
Front Pharmacol; 2018; 9():908. PubMed ID: 30150939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
